Study: add-on patents extend drug patent periods from two to over six years
1 outlet · 1L · 0C · 0R
First reported
1 / 1
We're still gathering coverage of this story.
A neutral account and the side-by-side comparison are written once at least 2 outlets have reported it. Here is the coverage so far.
Centre0 articles
No coverage yet.
Right0 articles
No coverage yet.
- 28 Sep 20:53 First Ars TechnicaLC To keep drug prices high, pharma has been piling up the patents
Times are when each article was published, or when we first saw it if the outlet gave no time.